INGR
Ingredion Incorporated NYSE$106.88
Mkt Cap $6.7B
52w Low $102.31
11.6% of range
52w High $141.78
50d MA $113.22
200d MA $117.29
P/E (TTM)
9.7x
EV/EBITDA
6.4x
P/B
1.6x
Debt/Equity
0.4x
ROE
3.9%
P/FCF
13.9x
RSI (14)
—
ATR (14)
—
Beta
0.69
50d MA
$113.22
200d MA
$117.29
Avg Volume
676.4K
About
Ingredion Incorporated, together with its subsidiaries, produces and sells starches and sweeteners for various industries. It operates through four segments: North America; South America; Asia-Pacific; and Europe, Middle East and Africa. The company offers sweetener products comprising glucose syrups, high maltose syrups, high fructose corn syrups, caramel colors, dextrose, polyols, maltodextrins,…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 3, 2026 | BMO | 2.59 | 2.53 | -2.3% | 120.41 | +0.4% | -0.4% | -0.4% | -1.3% | -0.2% | -0.9% | — |
| Nov 4, 2025 | BMO | 2.73 | 2.75 | +0.7% | 107.40 | +0.1% | +0.3% | +0.3% | -0.9% | +1.0% | +0.0% | — |
| Aug 1, 2025 | BMO | 2.78 | 2.87 | +3.2% | 126.37 | +0.8% | +0.2% | +0.2% | -0.1% | -0.9% | -0.1% | — |
| May 6, 2025 | BMO | 2.44 | 2.97 | +21.7% | 138.44 | -0.1% | -2.0% | -2.0% | -0.9% | -0.9% | -0.9% | — |
| Feb 4, 2025 | BMO | 2.54 | 2.63 | +3.5% | 127.13 | -0.7% | -0.7% | -0.7% | +0.2% | +0.6% | +0.3% | — |
| Nov 5, 2024 | BMO | 2.58 | 3.05 | +18.2% | 154.86 | -0.2% | -2.8% | -2.8% | -3.1% | -2.1% | -3.3% | — |
| Aug 6, 2024 | BMO | 2.49 | 2.87 | +15.3% | 127.95 | +0.5% | -1.2% | -1.2% | -0.9% | +1.7% | +0.2% | — |
| May 8, 2024 | BMO | 2.06 | 2.08 | +1.0% | 118.45 | +0.4% | +1.3% | +1.3% | +1.5% | +2.5% | -0.3% | — |
| Feb 6, 2024 | BMO | 1.87 | 1.97 | +5.3% | 109.71 | +0.0% | +0.9% | +0.9% | -0.2% | -1.4% | -0.6% | — |
| Nov 7, 2023 | BMO | 1.95 | 2.33 | +19.5% | 101.83 | -0.1% | -1.8% | -1.8% | -0.4% | +0.5% | +0.4% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 22 | Oppenheimer | Maintains | Outperform → Outperform | — | $113.20 | $113.26 | +0.1% | -0.5% | -0.3% | -0.5% | -0.2% | -0.2% |
| Apr 9 | UBS | Maintains | Neutral → Neutral | — | $113.56 | $112.94 | -0.5% | +1.2% | +1.0% | +0.0% | -0.5% | -0.8% |
| Feb 5 | UBS | Maintains | Neutral → Neutral | — | $119.96 | $119.28 | -0.6% | -0.9% | +0.1% | -0.6% | -1.0% | -0.1% |
| Feb 4 | Barclays | Maintains | Equal Weight → Equal Weight | — | $120.41 | $120.92 | +0.4% | -0.4% | -1.3% | -0.2% | -0.9% | -1.4% |
| Feb 4 | Stephens & Co. | Maintains | Equal Weight → Equal Weight | — | $120.41 | $120.92 | +0.4% | -0.4% | -1.3% | -0.2% | -0.9% | -1.4% |
| Nov 6 | Barclays | Downgrade | Overweight → Equal Weight | — | $107.70 | $105.75 | -1.8% | -1.2% | +0.7% | -0.3% | +1.5% | +0.4% |
| Nov 5 | UBS | Maintains | Neutral → Neutral | — | $107.40 | $107.49 | +0.1% | +0.3% | -0.9% | +1.0% | +0.0% | +1.8% |
| Nov 5 | Stephens & Co. | Maintains | Equal Weight → Equal Weight | — | $107.40 | $107.49 | +0.1% | +0.3% | -0.9% | +1.0% | +0.0% | +1.8% |
| Nov 5 | BMO Capital | Maintains | Market Perform → Market Perform | — | $107.40 | $107.49 | +0.1% | +0.3% | -0.9% | +1.0% | +0.0% | +1.8% |
| Oct 6 | UBS | Maintains | Neutral → Neutral | — | $120.87 | $120.23 | -0.5% | -0.5% | -0.2% | +0.6% | -1.1% | -0.9% |
Recent Filings
8-K
Ingredion Incorporated -- 8-K Filing
Ingredion Incorporated filed an 8-K disclosing forward-looking statements protected by safe harbor provisions, indicating the company may face uncertainty regarding future financial performance and business outcomes.
May 5
8-K · 2.02
!! High
Ingredion Incorporated -- 8-K 2.02: Earnings Results
Ingredion reported Q1 2026 earnings results, with the company disclosing its first-quarter financial performance and operational metrics through a May 5 press release.
May 5
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
INGR's appointment of an interim CFO signals potential financial leadership instability and suggests the company is searching for a permanent replacement, which could create near-term uncertainty for investors regarding financial strategy and decision-making.
Mar 25
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
A director compensation arrangement change suggests potential governance restructuring; investors should monitor whether this reflects leadership transition costs or strategic board composition shifts affecting future decision-making quality.
Mar 23
8-K · 8.01
!! High
Ingredion Incorporated -- 8-K 8.01: Material Event / Announcement
Ingredion's board consolidated leadership by naming CEO James P. Zallie as chairman, strengthening executive authority but potentially raising governance independence concerns for investors.
Feb 11
8-K
Ingredion Incorporated -- 8-K Filing
Ingredion's record full-year results were propelled by strong Texture Healthful Solutions and LATAM Food Industrial Ingredients performance, though U.S. Food Industrial Ingredients recovery lagged expectations.
Feb 3
Data updated apr 25, 2026 3:37pm
· Source: massive.com